Pictet North America Advisors 13F: Adds $628K to UNH Stake

Pictet North America Advisors raised its holdings in UnitedHealth Group Incorporated NYSE:UNH by 50.0% during the period, according to a Form 13F filing with the Securities and Exchange Commission on October 21, 2026.

UNH UnitedHealth Group Incorporated

$419.26 ▲ +27.09% year to date

1M 3M YTD

Daily close · Oct 20, 2026

What Changed in Pictet North America Advisors's UnitedHealth Group Incorporated Position

The firm acquired an additional 1,710 shares of the healthcare provider during the quarter. That brought its total ownership to 5,129 shares. The reported value of the stake reached $1,882,753 at the time of the filing.

UnitedHealth Group Incorporated Stock Up 0.7%

UnitedHealth Group Incorporated shares recently traded around $422.00 as of October 22, 2026. That puts the stock up about 1.2% since its closing price of $417.00 on October 21, 2026. The stock sits 8.8% above its 50-day moving average of $387.80 and 17.1% above its 200-day moving average of $360.27. Over the past year, shares have ranged from a low of $255.97 to a high of $461.62. The company currently has a market capitalization of $374.30 billion.

Recent Earnings

For its trailing twelve months, UnitedHealth Group Incorporated brought in $450.06 billion in revenue with earnings of $15.55 per share. The firm posted a net profit margin of 3.5% and a return on equity of 15.8%. Year-over-year revenue growth dipped slightly by 0.4%. The company's next earnings report is scheduled for January 12, 2027.

Dividend

UnitedHealth Group Incorporated pays an annual dividend of $9.28 per share, which gives it a dividend yield of 2.23%. The company's payout ratio sits at 57.6%, meaning it uses a little over half of its earnings to cover the payout.

Insider Buying and Selling at UnitedHealth Group Incorporated

Company insiders made a couple of sales prior to the filing. On August 5, 2026, officer Patrick Hugh Conway sold 500 shares at a price of $410.00 for a total of $205,000. Later on August 21, 2026, Conway sold another 1,169 shares at $390.00, totaling $455,910.

Analysts Set New Price Targets

Wall Street analysts have stayed active with their views on the stock. On October 14, 2026, Piper Sandler maintained its overweight rating while lifting its target to $504.00. TD Cowen maintained a hold rating with a $402.00 target on October 15, 2026. Bernstein kept an outperform rating on October 16, 2026, lowering its target to $500.00. On the same day, JP Morgan maintained an overweight rating and raised its target to $524.00. RBC Capital followed on October 20, 2026, keeping an outperform rating and boosting its target to $498.00. The stock currently holds a consensus recommendation of buy from 25 analysts, with a mean price target of $478.12.

About UnitedHealth Group Incorporated

UnitedHealth Group Incorporated operates as a health care company through multiple divisions, including its care delivery and benefits operations. The firm provides health care plans, wellness programs, and care management services to consumers, employers, and public-sector entities. Tracking institutional changes like Pictet North America Advisors's increased stake offers a window into how larger investors position themselves within major healthcare providers.

Bottom Line

Investors will look ahead to the company's next earnings report on January 12, 2027, for further updates on financial performance. Future SEC filings will also show whether institutional interest in the healthcare provider continues to grow.